-+ 0.00%
-+ 0.00%
-+ 0.00%

*Altimmune Plans to Use Proceeds to Fund Upcoming Phase 3 Trial in MASH, and for Working Capital, General Corporate Purposes >ALT

Dow Jones·04/23/2026 03:29:00

Please log in to view news